An investigation into the safety, tolerability, and efficacy of high dose rivastigmine treatment in Alzheimer's disease

被引：0
|
作者：
Shua-Haim, JR [1 ]
Pass, MD [1 ]
Patel, S [1 ]
Lee, P [1 ]
Patel, P [1 ]
机构：
[1] Jersey Shore Univ Med Ctr, Neptune, NJ USA
来源：
NEUROBIOLOGY OF AGING | 2004年 / 25卷
关键词：
D O I：
10.1016/S0197-4580(04)80659-6
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：S196 / S196
页数：1
相关论文
共 50 条
  • [31] An open randomized comparative study of clinical efficacy and safety of huperzine A and rivastigmine in treatment of mild to moderate Alzheimer's disease
    Wu, Y. C.
    Zhao, Y. B.
    Xie, Y. Y.
    Wang, W. Z.
    EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 198 - 199
  • [32] Response to comments on Efficacy and safety of rivastigmine in patients with Alzheimer's disease who failed to benefit from treatment with donepezil
    Auriacombe, S
    Pere, JJ
    CURRENT MEDICAL RESEARCH AND OPINION, 2002, 18 (06) : IV - VI
  • [33] Efficacy and Safety of Donepezil, Galantamine, Rivastigmine, and Memantine for the Treatment of Alzheimer's Disease: A Systematic Review and Meta-Analysis
    Tan, Chen-Chen
    Yu, Jin-Tai
    Wang, Hui-Fu
    Tan, Meng-Shan
    Meng, Xiang-Fei
    Wang, Chong
    Jiang, Teng
    Zhu, Xi-Chen
    Tan, Lan
    JOURNAL OF ALZHEIMERS DISEASE, 2014, 41 (02) : 615 - 631
  • [34] The efficacy and safety of memantine for the treatment of Alzheimer's disease
    Matsunaga, Shinji
    Kishi, Taro
    Nomura, Ikuo
    Sakuma, Kenji
    Okuya, Makoto
    Ikuta, Toshikazu
    Iwata, Nakao
    EXPERT OPINION ON DRUG SAFETY, 2018, 17 (10) : 1053 - 1061
  • [35] Safety/Tolerability and Efficacy of Rivastigmine in Taiwanese Patients with Alzheimer’s DiseaseA Prospective Post-Marketing Surveillance Study
    Pai-Yi Chiu
    Dao-En Dai
    Hai-Pei Hsu
    Chao Lee
    Juei-Jueng Lin
    Hung-Chou Kuo
    Ying-Chih Huang
    Yung-Chang Liu
    Ching-Piao Tsai
    Clinical Drug Investigation, 2009, 29 : 729 - 738
  • [36] Donepezil: Tolerability and safety in Alzheimer's disease
    Pratt, RD
    Perdomo, CA
    Surick, IW
    Ieni, JR
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2002, 56 (09) : 710 - 717
  • [37] A head to head study of donepezil, rivastigmine, and galantamine for the treatment of Alzheimer's disease: Safety, tolerability, clinical and caregiver impressions after 9 months of treatment
    Shua-Haim, JR
    Pass, MD
    Patel, S
    Patel, S
    Lee, P
    Patel, P
    Smith, J
    NEUROBIOLOGY OF AGING, 2004, 25 : S208 - S208
  • [38] Efficacy of rivastigmine in subjects with moderately severe Alzheimer's disease
    Burns, A
    Spiegel, R
    Quarg, P
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2004, 19 (03) : 243 - 249
  • [39] Efficacy of rivastigmine tartrate, transdermal system, in Alzheimer's disease
    Nieto, Rachel A.
    Deardorff, William James
    Grossberg, George T.
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (06) : 861 - 870
  • [40] Efficacy of rivastigmine on loss of appetite in patients with Alzheimer's disease
    Tsuno, N.
    Mori, T.
    Nakamura, Y.
    EUROPEAN PSYCHIATRY, 2017, 41 : S176 - S177
12345